Israel’s Kamada (reported here previously) has signed a deal to supply Israel’s Health ministry with its plasma-based hyperimmune immunoglobulin (IgG) product. The product treats COVID-19 patients with pneumonia and is currently in Phase 1 & 2 trials in Israel. https://nocamels.com/2020/10/kamada-deal-supply-israel-health-ministry-covid-19-antibody/ … Continue reading →

11 of the 12 trial patients treated with the IgG Covid-19 treatment from Israel’s Kamada (reported here previously) have now recovered and been discharged from hospital. https://nocamels.com/2020/09/early-trial-results-kamada-covid-19-antibodies/

Three of the first critical Covid-19 patients treated with the new IgG plasma-derived “passive vaccine” product developed by Israel’s Kamada and Hadassah Medical Center (reported here previously), have made a rapid recovery and have now been discharged from Hadassah hospital. … Continue reading →

Israel’s Kamada (reported here previously) has completed manufacturing the first batch of its plasma-derived Immunoglobulin G (IgG) product for Covid-19 patients. Initial vials of the antibody have been made available for compassionate use in Israel. https://www.calcalistech.com/ctech/articles/0,7340,L-3834010,00.html

Israeli biotech Kamada (see here) has partnered Italy’s Kedrion to develop a human plasma-derived Anti-SARs-COV-2 product. Kamada will use its proprietary IgG platform technology and Kedrion will provide plasma from donors who have recovered from the virus. https://www.kedrion.com/kedrion-and-kamada-announce-collaboration-anti-covid-19-igg-0

Israel’s 2019 Genesis Prize winner, Natan Sharansky, donated his $1 million prize to 10 Israeli startups developing innovations to combat Covid-19. The 10 are Kamada, Pluristem, Sight Diagnostics, Sonovia, Biobeat, EyeControl, K Health, Picodya, IAI and MyZeppi. https://nocamels.com/2020/12/sharansky-genesis-prize-10-companies-covid/ https://www.genesisprize.org/press-center/2020-12-24-genesis-prize-and-start-up-nation-central-announce-winners-of-the-competition-in-honor-of-natan-sharansky

Jerusalem’s Hadassah Hospital is cautiously optimistic after the world’s first passive immunization of a critically ill coronavirus patient. After an injection of Kamada’s IgG antibody product (see here), a CT-scan of the lungs showed some improvement and doctors are hopeful … Continue reading →